证券代码：688661 证券简称：和林微纳 公告编号：2024-024 苏州和林微纳科技股份有限公司 2023 年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 新增无限售条件流 通股份上市日 | 现金红利发放日 | | --- | --- | --- | --- | | 2024/6/3 | 2024/6/4 | 2024/6/4 | 2024/6/4 | 一、 通过分配、转增股本方案的股东大会届次和日期 本次利润分配及转增股本方案经公司 2024 年 5 月 17 日的 2023 年年度股东大 会审议通过。 二、 分配、转增股本方案 1. 发放年度：2023 年年度 2. 分派对象： 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 公司存在首发战略配售股份，首发战略配售股份已全部上市流通 是否涉及差异化分红送转：否 每股分配比例，每股转增比例 每股现金 ...

Investment Rating - The report initiates coverage with a "Buy" rating for the company [34]. Core Views - The company is a leading player in the domestic semiconductor testing probe industry, with significant growth in R&D investment over the past two years [10][11]. - The semiconductor testing probe market is expected to grow steadily, with the global market projected to increase from $1.594 billion in 2021 to $2.741 billion by 2025, reflecting a compound annual growth rate (CAGR) of 14.51% [30]. - The company is positioned to benefit from the recovery in demand for semiconductor testing probes, particularly as it expands its customer base and product offerings [24][34]. Summary by Sections 1. Semiconductor Testing Probes: Key Components in Chip Testing - The semiconductor testing probe is a critical component in the chip testing process, with opportunities arising from domestic substitution and technological innovation [54]. 2. Company Overview: Leading Domestic Semiconductor Testing Probe Provider - The company has established itself as a leader in the domestic semiconductor testing probe market, with a strong competitive position in MEMS microelectronic components internationally [11][23]. 2.1 R&D Investment Growth - The company has significantly increased its R&D investment, which is expected to provide a solid foundation for future growth [10][11]. 2.2 FT Probe Business Recovery and CP Probe Growth - The FT probe business, which saw high growth driven by major clients like NVIDIA, faced challenges in 2022-2023 but is expected to recover in 2024 as demand rebounds [24][34]. 3. Financial Projections - The company forecasts net profits of 1.06 billion, 1.70 billion, and 2.33 billion yuan for 2024, 2025, and 2026, respectively, with corresponding price-to-earnings (PE) ratios of 42X, 26X, and 19X [34][35].

Financial Data and Key Metrics Changes - The company has seen a significant increase in demand for AI GPU testing, with a 20% quarter-over-quarter growth in Q2 2024 [7] - The value of H100 probes is reported to be between $3 to $5, while the GB200 can reach $13 to $15, indicating a rise in both volume and price [2] Business Line Data and Key Metrics Changes - The company is expanding its GPU-related product lines, showcasing six new products at the Munich Shanghai Electronics Fair, half of which are related to GPU testing consumables and cooling materials [3] - The introduction of advanced packaging technology using glass substrates is expected to drive demand for semiconductor testing, despite higher costs compared to silicon and organic substrates [1] Market Data and Key Metrics Changes - The company is positioned as a key supplier for NVIDIA, particularly in the high-end testing probe and related components for AI chips, which is expected to benefit from NVIDIA's increased production [2][8] - The market for semiconductor testing is anticipated to grow, with the GB200 semiconductor testing consumables being recognized as a unique supply opportunity [16] Company Strategy and Development Direction - The company is focusing on expanding its presence in the AI and high-performance computing sectors, leveraging its unique position as a supplier for major clients like NVIDIA [2][16] - The strategy includes diversifying product offerings beyond probes to include various testing and packaging solutions for high-performance chips [3][4] Management Comments on Operating Environment and Future Outlook - Management has indicated that the demand for AI-related products is robust, with expectations for continued growth in the semiconductor testing market driven by advancements in chip technology [7][16] - The company is optimistic about its role in the supply chain for emerging technologies, particularly in the AR/VR/MR applications [6] Other Important Information - The company is the sole supplier of precision shielding for Apple's upcoming IR products, with an expected release of around 10 million units in 2025 [11] - The company has successfully expanded its partnerships, with significant growth in its probe business attributed to NVIDIA's large-scale chip usage [9] Q&A Session Summary Question: Is the company's probe business benefiting from NVIDIA's large-scale use of A100 and H100 chips? - Yes, the probe business is expected to meet the demand surge from NVIDIA's chip production [8] Question: Will the company continue to be part of Apple's IR supply chain? - The company is confirmed to remain a supplier for Apple's precision shielding in the upcoming IR products [11] Question: What is the outlook for the company's semiconductor testing business? - The semiconductor testing business is anticipated to grow significantly, driven by the demand for larger chips and advanced testing solutions [7][16]

证券代码：688661 证券简称：和林微纳 公告编号：2024-023 苏州和林微纳科技股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 14 | | --- | --- | | 普通股股东人数 | 14 | | 2、出席会议的股东所持有的表决权数量 | 34,177,552 | | 普通股股东所持有表决权数量 | 34,177,552 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 38.0281 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 38.0281 | （四） 表决方式是否符合《公司法》及公司章程的规定，大会主持情况等。 本次会议由公司董事会召集，董事长骆兴顺先生主持。会议采用现场投票和 （一） 股 ...

江苏世纪同仁律师事务所关于 苏州和林微纳科技股份有限公司 2023 年年度股东大会的法律意见书 苏州和林微纳科技股份有限公司： 根据《公司法》《证券法》和中国证监会《上市公司股东大会规则》等法律、 法规和规范性文件以及《公司章程》的规定，本所受贵公司董事会的委托，指派 本所律师见证公司2023年年度股东大会，并就本次股东大会的召集、召开程序、 出席会议人员资格、召集人资格、表决程序和表决结果的合法有效性等事项出具 法律意见。 为出具本法律意见书，本所律师对本次股东大会所涉及的有关事项进行了审 查，查阅了相关会议文件，并对有关问题进行了必要的核查和验证。 2.本次股东大会的投票方式 本所律师同意将本法律意见书随公司本次股东大会决议一并公告，并依法对 本法律意见书承担相应的责任。 本所律师根据相关法律、法规和规范性文件的要求，按照律师行业公认的业 务标准、道德规范和勤勉尽责精神，出具法律意见如下： 一、关于本次股东大会的召集、召开程序 1.本次股东大会的召集 本次股东大会由董事会召集。2024年4月25日，公司召开了第二届董事会第 十次会议，审议通过了《关于召开公司2023年年度股东大会的议案》，决议于2024 ...

苏州和林微纳科技股份有限公司 2023 年年度股东大会 会议材料 证券代码：688661 证券简称：和林微纳 二〇二四年五月 中国苏州 | 2023 | 年年度股东大会会议须知 2 | | --- | --- | | 2023 | 年年度股东大会会议议程 4 | | 2023 | 年年度股东大会会议议案 6 | 苏州和林微纳科技股份有限公司 2023 年年度股东大会会议资料 苏州和林微纳科技股份有限公司 2023 年年度股东大会会议须知 为了维护苏州和林微纳科技股份有限公司（下称"公司"）全体股东的合法 权益，确保股东大会的正常秩序，保证股东大会如期、顺利召开，根据《中华人 民共和国公司法》、《中华人民共和国证券法》、《上市公司股东大会规则（2023 年修订）》、《苏州和林微纳科技股份有限公司章程》（下称《公司章程》）以及《苏 州和林微纳科技股份有限公司股东大会议事规则》等有关规定，特制定本须知： 一、会议期间，全体出席人员应以维护股东的合法权益、保证大会的正常秩 序和议事效率为原则，认真履行法定义务，自觉遵守大会纪律，不得侵犯公司和 其他股东的合法权益，不得扰乱股东大会的正常召开秩序。 二、为保证股东大会的 ...

Group 1: Financial Performance - In Q1 2024, the revenue from testing probes accounted for approximately 20% of the total revenue [1] - The company reported an overall loss for the year 2023 but still decided to distribute dividends and increase capital [1] - The probe business showed positive profits in Q1 2024, although specific profit figures were not disclosed [2] Group 2: Business Development and Strategy - The company is focusing on expanding its MEMS components and semiconductor probe sectors, with increased R&D investment [2] - New effective domestic and international customers have been validated for the FT probe business [2] - The company is committed to continuous technical improvements and cost reduction to enhance efficiency [2] Group 3: Investor Relations and Communication - The investor relations activity was held on May 6, 2024, with participation from various investors [1] - Key company representatives included the Chairman and General Manager, CFO, and Board Secretary [1] - The company emphasized its commitment to investor returns while ensuring normal operations [1]

Financial Performance - The company's operating revenue for Q1 2024 reached RMB 96.68 million, representing a year-on-year increase of 124.93%[5] - The net profit attributable to shareholders of the listed company was RMB -5.42 million, with a decrease in net profit excluding non-recurring gains and losses of RMB -6.16 million[5] - The company reported a significant increase in contract liabilities by 106.50%, primarily due to an increase in advance payments received[8] - The company experienced a 129.80% increase in operating costs, mainly due to increased revenue from precision shielding covers and precision structural components[9] - Total operating revenue for Q1 2024 reached ¥96,677,557.38, a significant increase of 125.7% compared to ¥42,981,036.44 in Q1 2023[17] - Total operating costs for Q1 2024 were ¥103,073,827.73, up 68.8% from ¥61,004,575.48 in Q1 2023[17] - Net profit for Q1 2024 was a loss of ¥5,401,035.13, an improvement from a loss of ¥7,162,013.24 in Q1 2023[18] - The company recorded a total comprehensive loss of ¥6,478,485.86 for Q1 2024, compared to a loss of ¥7,199,450.21 in Q1 2023[19] Cash Flow and Assets - The net cash flow from operating activities was RMB 2.02 million, with a significant increase in accounts receivable financing by 66.03% due to an increase in bank acceptance bills received[8] - Cash flow from operating activities generated a net inflow of ¥2,019,890.51, compared to a net outflow of ¥14,876,052.99 in Q1 2023[20] - Cash flow from investment activities showed a net inflow of ¥25,424,588.30, down from ¥146,321,995.54 in Q1 2023[20] - The cash and cash equivalents increased to RMB 750,704,150.09 from RMB 712,371,535.99, representing a growth of about 5.4%[13] - The beginning balance of cash and cash equivalents was $706,997,560.42, while the ending balance was $745,408,424.52[21] - The total assets as of March 31, 2024, were RMB 1,394,400,091.56, up from RMB 1,378,379,178.46, reflecting a growth of about 1.2%[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 6,280[10] - The largest shareholder, Luo Xingshun, holds 34.33% of the shares, totaling 30,851,653 shares[11] Liabilities and Equity - Total liabilities increased to RMB 175,758,450.71 from RMB 153,788,998.06, which is an increase of approximately 14.2%[16] - The company's equity attributable to shareholders decreased to RMB 1,218,593,276.87 from RMB 1,224,558,823.12, a decline of about 0.5%[16] - Short-term borrowings increased to RMB 41,797,540.28 from RMB 29,784,408.55, representing a significant rise of approximately 40.4%[16] - The company reported a decrease in undistributed profits to RMB 70,267,897.94 from RMB 75,685,887.50, a decline of about 7.4%[16] Research and Development - Research and development expenses totaled RMB 15.77 million, accounting for 16.31% of operating revenue, a decrease of 22.57 percentage points compared to the previous year[6] - Research and development expenses for Q1 2024 were ¥15,771,736.67, slightly down from ¥16,712,888.96 in Q1 2023[17] Inventory and Accounts Receivable - Accounts receivable decreased to RMB 102,683,574.15 from RMB 116,523,632.98, indicating a reduction of approximately 11.9%[13] - Inventory rose to RMB 85,925,090.90 from RMB 70,228,380.07, marking an increase of around 22.4%[15]

关于苏州和林微纳科技股份有限公司 2023 年度募集资金存放与使用情况鉴证报告 【天衡专字(2024)00712 号】 苏州和林微纳科技股份有限公司全体股东: 我们接受委托,对后附的苏州和林微纳科技股份有限公司(以下简称"贵公司")截至 2023年 12 月 31 日止的《2023年度募集资金存放与实际使用情况的专项报告》进行了鉴证工作。 一、管理层的责任 按照中国证券监督管理委员会《上市公司监管指引第 2 号-上市公司募集资金管理和使用的监管 要求(2022年修订)》、上海证券交易所《上海证券交易所上市公司自律监管指引第 1 号-规范运作》 及相关格式指引规定,编制募集资金存放与使用情况的专项报告,并保证其内容真实、准确、完整, 不存在虚假记载、误导性陈述或重大遗漏是贵公司管理层的责任。 二、注册会计师的责任 我们的责任是在实施鉴证工作的基础上对贵公司募集资金年度存放与使用情况发表意见。我们 按照《中国注册会计师其他鉴证业务准则第 3101 号-历史财务信息审计或审阅以外的鉴证业务》的 规定执行了审核工作,该准则要求我们遵守中国注册会计师职业道德守则,计划和执行审核工作, 以对墓集资金年度存放与使用情况报告 ...

国泰君安证券股份有限公司 关于苏州和林微纳科技股份有限公司 2023 年度持续督导跟踪报告 二、保荐人和保荐代表人发现的问题及整改情况 国泰君安证券股份有限公司（以下简称"国泰君安"、"保荐人"）作为苏 州和林微纳科技股份有限公司（以下简称"公司"、"和林微纳"）首次公开发 行股票并在科创板上市和 2021 年度向特定对象发行股票的持续督导机构，根据 《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》《科 创板上市公司持续监管办法（试行）》《上市公司监管指引第 2 号——上市公司募 集资金管理和使用的监管要求》《上海证券交易所科创板上市公司自律监管指引 第 1 号——规范运作》等有关规定，对和林微纳进行持续督导，并出具本持续督 导跟踪报告。 1 序号 工作内容 持续督导情况 1 建立健全并有效执行持续督导工作制度，并 针对具体的持续督导工作制定相应的工作 计划 保荐人已建立健全并有效执行了持 续督导制度，并制定了相应的工作计 划 2 根据中国证监会相关规定，在持续督导工作 开始前，与上市公司签署持续督导协议，明 确双方在持续督导期间的权利义务，并报上 海证券交易所备案 保荐人已与和林微纳签订 ...